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Abstract
Background: The variability in the clinical or pathological presentation of transmissible
spongiform encephalopathies (TSEs) in sheep, such as scrapie and bovine spongiform
encephalopathy (BSE), has been attributed to prion protein genotype, strain, breed, clinical
duration, dose, route and type of inoculum and the age at infection. The study aimed to describe
the clinical signs in sheep infected with the BSE agent throughout its clinical course to determine
whether the clinical signs were as variable as described for classical scrapie in sheep. The clinical
signs were compared to BSE-negative sheep to assess if disease-specific clinical markers exist.
Results: Forty-seven (34%) of 139 sheep, which comprised 123 challenged sheep and 16 undosed
controls, were positive for BSE. Affected sheep belonged to five different breeds and three different
genotypes (ARQ/ARQ, VRQ/VRQ and AHQ/AHQ). None of the controls or BSE exposed sheep
with ARR alleles were positive. Pruritus was present in 41 (87%) BSE positive sheep; the remaining
six were judged to be pre-clinically infected. Testing of the response to scratching along the dorsum
of a sheep proved to be a good indicator of clinical disease with a test sensitivity of 85% and
specificity of 98% and usually coincided with weight loss. Clinical signs that were displayed
significantly earlier in BSE positive cases compared to negative cases were behavioural changes,
pruritic behaviour, a positive scratch test, alopecia, skin lesions, teeth grinding, tremor, ataxia, loss
of weight and loss of body condition. The frequency and severity of each specific clinical sign usually
increased with the progression of disease over a period of 16–20 weeks.
Conclusion: Our results suggest that BSE in sheep presents with relatively uniform clinical signs,
with pruritus of increased severity and abnormalities in behaviour or movement as the disease
progressed. Based on the studied sheep, these clinical features appear to be independent of breed,
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BMC Veterinary Research 2008, 4:16 http://www.biomedcentral.com/1746-6148/4/16affected genotype, dose, route of inoculation and whether BSE was passed into sheep from cattle
or from other sheep, suggesting that the clinical phenotype of BSE is influenced by the TSE strain
more than by other factors. The clinical phenotype of BSE in the genotypes and breed studied was
indistinguishable from that described for classical scrapie cases.
Background
After the discovery that bovine spongiform encephalopa-
thy (BSE) and variant Creutzfeldt-Jakob disease (v-CJD)
were caused by the same agent [1] research on transmissi-
ble spongiform encephalopathies (TSEs) targeted other
farm animal species that may harbour the BSE agent.
Sheep were a particular concern because scrapie, another
TSE, has been endemic in sheep flocks for more than 200
years, and if sheep had been fed BSE infected meat and
bone meal, there would have been the possibility that it
could go undetected if mistaken for scrapie. Several stud-
ies have been conducted at the Veterinary Laboratories
Agency (VLA) since 1997 to investigate the clinical presen-
tation, pathology, pathogenesis, diagnosis and transmis-
sion of BSE in sheep.
As for scrapie, the susceptibility of sheep to BSE is largely
determined by polymorphisms (principally at codons
136, 154 and 171) of the gene that encodes the prion pro-
tein (PrP). Sheep most susceptible are homozygous for
alanine at codon 136, glutamine at codon 171, and either
arginine (ARQ/ARQ) or histidine (AHQ/AHQ) at codon
154 [2], whereas arginine at codon 171 (ARR) is associ-
ated with increased resistance [3]. Although intracerebral
infection of ARR/ARR sheep with BSE has produced clini-
cal disease [4], it is not known whether oral infection can
produce clinical disease in this genotype within the natu-
ral life span of sheep. A more recent study proposed that
other polymorphisms at codons 137, 142, 168 and 176 of
the PrP gene may also influence the susceptibility of sheep
to experimental BSE [5,6].
Despite considerable variation in the clinical signs of
scrapie in sheep, three main types have been described, a
pruritic form, a paralytic form without pruritic behaviour,
and an atypical form, which usually includes signs of a
cerebellar disease [7-11]. It is largely unknown which fac-
tors determine the clinical presentation but it may be the
result of differences between strains [12,13], genotypes
[14] or clinical duration [14,15]. Other factors, such as
breed, dose or age at infection may also be contributory;
for example, differences in the vacuolar lesion profiles in
scrapie have been attributed partly to the sheep breed
[16].
The first study conducted in the UK described BSE in
sheep as an acute disease with a duration of less than one
week regardless of the route of inoculation (intracerebral
or oral), which was characterised by ataxia resulting in
recumbency; pruritus was usually absent [17,18]. This was
subsequently confirmed in an oral transmission study [2].
By contrast, intraperitoneal infection of a sheep with BSE
resulted in a protracted clinical course and at the late-stage
intense pruritus and ataxia [19], and in a Dutch study four
orally inoculated sheep developed clinical signs that
included ataxia, head tremor and a nibble reflex [20]. A
more detailed clinical study of 28 sheep inoculated intrac-
erebrally or intravenously with BSE suggested that BSE is
"more likely to present with sudden onset of ataxia in the
absence of pruritus compared to scrapie although 42%
presented with pruritus alone and 25% displayed pruritus
in combination with ataxia" [21]. Observed variations
were attributed to the different routes of inoculation, dif-
ferent doses and different inocula (BSE brain or blood
from BSE-affected sheep).
The objective of this paper is to describe the clinical signs
of BSE in sheep, throughout its clinical course and at end-
stage. The bulk of the data concerns ARQ homozygous
Suffolk and Romney sheep, which were orally challenged
with the BSE agent or acquired the infection naturally in
an experimental flock. A small number of other breeds
and genotypes and two sheep inoculated intracerebrally
were also studied. To evaluate whether disease-associated
clinical markers exist, the clinical features were compared
with those of culled sheep of different genotypes and
breeds that had not been challenged with BSE (cohort
controls) or had been challenged but not confirmed path-
ologically as BSE cases. For the purpose of this paper, a
BSE case is an animal that developed undisputable clinical
features of BSE and was positive on postmortem examina-
tion of the brain.
Results
Forty-seven sheep (34%) were positive for BSE by post-
mortem tests on brain tissue. Eleven of these were culled
at pre-determined time points to study BSE pathogenesis
and tissue distribution. The numbers of BSE cases in sheep
of each genotype and breed and the doses, routes of infec-
tion and incubation periods are detailed in Table 1. Table
2 lists the details of unchallenged control sheep and chal-
lenged sheep without pathological confirmation of BSE.
Clinical assessment prior to cull
Table 3 compares selected clinical signs observed in BSE-
positive and negative sheep up to four weeks prior to cull.Page 2 of 15
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ing, was displayed too infrequently to be used as a clinical
marker.
Pruritus, defined as the occurrence of a positive scratch
test (see Additional files 1 and 2: movies 1 and 2 showing
sheep with a positive scratch test) or – if this was not
tested – a self-induced scratch response (see Additional
file 3: movie 3), occasional or frequent rubbing, scratch-
ing or nibbling (see Additional file 4: movie 4 showing
two sheep with pruritic behaviour), was present in 38
(86%) out of 44 BSE positive sheep. In advanced cases in
ARQ homozygotes, a clear nibbling response could some-
times be elicited by merely touching the sheep (see Addi-
tional file 5: movie 5 of a sheep with a strong scratch
response on touch), whereas nibbling was less pro-
nounced or required more forceful scratching in the AHQ
homozygous Cheviots (see Additional file 6: movie 6
showing a sheep that exhibits a more evident response to
scratching when not restrained).
The clinical signs displayed by the six non-pruritic BSE
cases, which were culled at pre-determined time-points,
are shown in Table 4.
Based on the criteria that a positive scratch test was an
indication of BSE infection in the brain (by means of PrPd
detection), the test sensitivity was 84% and test specificity
Table 1: Genotype, breed distribution with inoculation details and incubation periods of confirmed BSE cases
Genotype Breed Dose (at age) n IP
AHQ/AHQ Cheviot 5 g orally (4–9 months) 4 17, 17, 18, 18
ARQ/ARQ Poll 5 g orally (6 months) 2 22, 29
Dorset 0.5 g orally (6 months) 1 25
Romney 5 g orally (4–7 months) 17 29 (2.1)
0.5 g orally (6 months) 2 23, 24
"Natural infection" (experimental flock) 1 24
Suffolk 5 g orally (4–8 months) 14 24 (0.9)
0.5 g orally (6 months) 1 25
"Natural infection" (experimental flock) 1 21
1 ml intracerebrally (8 months) 2 17, 18
VRQ/VRQ Cheviot 5 g orally (4 months) 2 51, 54
IP = Incubation period in months (always rounded down), defined as time period from inoculation (birth for naturally infected animals) to cull. The 
mean incubation period with the standard error in parentheses is given if the numbers exceed four. Excluded are the scheduled culls (seven 
Romney, four Suffolk sheep) in the oral pathogenesis studies (e.g. the pre-clinical cases).
Table 2: Genotype, breed distribution with inoculation details and incubation periods of BSE-negative sheep
Genotype Breed n Oral dose (at age) IP
Unchallenged (controls) ARQ/ARQ Romney 3 None 15, 21, 34
Suffolk 2 None 3, 15
ARQ/ARR Romney 4 None 10, 21, 33, 45
ARR/ARR Romney 4 None 9, 21, 33, 45
Suffolk 3 None 9, 34, 45
TOTAL 16
Challenged ARQ/ARQ Romney 5 5 g (6 months) 12 (1.22)
Suffolk 7 5 g (4 months) 9 (2.4)
Suffolk 1 0.5 g (6 months) 38
ARQ/ARR Romney 17 5 g (6 months) 41 (6.7)
Romney 1 0.05 g (6 months) 50
Suffolk 13 5 g (4 months) 32 (6.1)
ARR/ARR Romney 17 5 g (6 months) 42 (7.3)
Suffolk 15 5 g (4 months) 29 (3.4)
TOTAL 76
IP = Incubation period in months (always rounded down), defined as time period from inoculation to cull and – for unchallenged animals in the oral 
BSE pathogenesis study – from test group exposure and cull. The mean incubation period with the standard error in parentheses is given if the 
numbers exceed four.Page 3 of 15
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Value = 91%, data see Table 3). Of the six cases that were
positive on postmortem tests without displaying a posi-
tive scratch test (ARQ/ARQ Suffolk and Romney sheep),
three were culled at 16 months post inoculation (mpi)
and displayed no specific signs (SM1391, SM1430,
SP3652, see Table 4) whilst the other three animals were
killed between 21 and 22 mpi and displayed pruritic
behaviour, such as frequent or occasional rubbing and
nibbling in combination with alopecia in two and a self-
induced nibble reflex in one animal. One sheep with a
positive scratch test on two consecutive examinations that
had no detectable PrPd in the brain and lymphoreticular
tissue was a dosed ARQ/ARQ Suffolk culled at 16 mpi,
which did not display any other clinical signs except for
one event of rubbing. Other pruritic behaviour (a self-
induced nibble reflex, occasional or frequent rubbing,
scratching or nibbling) was observed in 19 (29%) of 65
BSE-negative sheep (54 dosed sheep, 11 undosed con-
trols) that were observed sufficiently within four weeks
prior to cull. The genotype of these sheep was either ARQ/
ARR (n = 6) or ARR/ARR (n = 13); all were dosed with the
Table 3: Selected clinical signs displayed up to 4 weeks prior to cull
Postmortem diagnosis BSE POSITIVE BSE NEGATIVE P
Clinical sign Present Absent Present Absent *
Behavioural abnormalities
Change in behaviour (dull or nervous) 27 (61%) 17 (39%) 7 (10%) 60 (90%) +++
Bruxism when handled 11 (27%) 30 (73%) 4 (6%) 58 (94%) +
Bruxism when free during examination 6 (15%) 35 (85%) 4 (6%) 58 (94%) ns
Bruxism frequently during observations 7 (23%) 12 (40%) 0 (0%) 58 (89%) +++
Bruxism occasionally during observations 6 (20%) 0 (0%) +++
Bruxism during observations once 5 (17%) 7 (11%) ns
Sensory abnormalities (pruritus)
Rubbing or scratching frequently 19 (63%) 2 (7%) 8 (12%) 27 (43%) +++
Rubbing or scratching occasionally 7 (23%) 11 (17%) +
Rubbing or scratching once 2 (7%) 19 (28%) ns
Nibbling frequently 5 (17%) 13 (43%) 0 (0%) 43 (68%) +
Nibbling occasionally 7 (23%) 0 (0%) ++
Nibbling once 5 (17%) 20 (32%) ns
Positive scratch test 35 (85%) 6 (16%) 1 (2%) 61 (98%) +++
Fleece changes 19 (40%) 28 (60%) 10 (11%) 77 (89%) ++
Alopecia 26 (55%) 21 (45%) 3 (3%) 86 (97%) +++
Skin lesions 15 (32%) 32 (68%) 3 (3%) 86 (97%) +++
Self-induced scratch response 27 (75%) 9 (25%) 3 (5%) 62 (95%) +++
Abnormalities in movement
Tremors 22 (52%) 20 (48%) 4 (6%) 64 (94%) +++
Ataxia 23 (49%) 24 (51%) 1 (1%) 90 (99%) +++
Physical changes
Weight loss >10% 12 (25%) 9 (22%) 1 (2%) 48 (70%) +++
Weight loss 5–10% 5 (13%) 1 (2%) +
Weight loss < 5% 15 (35%) 7 (10%) +++
Weight remained the same 2 (5%) 11 (16%) ns
Loss of body condition 20 (57%) 15 (43%) 13 (34%) 25 (66%) ns
* P-values: + ≤ 0.01;
++ ≤ 0.001;
+++ ≤ 0.0001;
ns statistically not significant (P > 0.05)
The BSE-negative subset included challenged and unchallenged animals. The homogeneity of the clinical signs within this subset was proven by 
Fisher's exact test (P > 0.05)Page 4 of 15
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mpi, SEM 3).
All confirmed BSE cases that were ataxic prior to cull (see
Additional file 7: movie 7 of a sheep with mild proprio-
ceptive deficits and hind limb ataxia) also displayed pru-
ritus, characterised by either a positive scratch test (see
Additional file 5: movie 5 showing the same animal with
a positive scratch test) or – if this was not tested (six ani-
mals) – by frequent rubbing, scratching and nibbling.
The combination of changed behaviour, pruritus and
ataxia was displayed by 17 (40%) of 43 BSE positive cases
that had each sign assessed but was not observed in BSE-
negative sheep.
Over-reactivity to auditory stimuli, such as repeated
flinching in response to a hand clap, was displayed by
three (7%) of 42 tested BSE-affected sheep and none of
the BSE-negative sheep. The assessment of cranial nerve
function was unremarkable in most cases except for either
unilateral or bilateral decreases in the menace response in
three (8%) of 39 BSE-affected sheep (not observed in any
of the BSE negative culls). Sheep of all groups (BSE posi-
tive and BSE negative including unchallenged controls),
particularly Romney sheep, often exhibited a weak pupil-
lary light response. As visual deficits were not evident and
no eye abnormalities were apparent by indirect ophthal-
moscopy, this finding was considered to be normal.
Intercurrent diseases
Six sheep with at least one ARR allele were culled with
intercurrent diseases and had a negative BSE test result on
brain and lymphoreticular tissue.
A Romney wether (SR6128, ARQ/ARR, orally dosed with
0.05 g of BSE brainstem at six months of age and culled at
50 mpi) presented with progressive weight loss, bruxism
(teeth grinding) during handling and alopecia on the
bridge of the nose. Increased serum liver enzyme activity
was suggestive of a liver disease; hepatitis was diagnosed
histopathologically.
A Suffolk wether (SP3611, ARQ/ARR, orally dosed with 5
g of BSE brainstem at five months of age and culled at 90
mpi) developed a head tremor at rest. This sheep had a
stiff, mildly ataxic gait and responded to scratching of the
dorsum with lip tremor and head tilt (inconclusive scratch
test). Haematology and blood biochemistry were unre-
markable. Degenerative osteochondritis of the femoro-
tibial joints and acute oedema of the brain suggestive of
enterotoxaemia following clostridial replication was diag-
nosed, although there was no clinical and pathological
evidence of enteritis.
Another four sheep had displayed episodes of lateral
recumbency with paddling of the limbs, which were
described as "fits" by animal husbandry staff and may
have been seizures.
A Romney ewe (SM1408, ARQ/ARR, orally dosed with 5 g
of BSE brainstem at six months of age and culled at 85
mpi) was found recumbent in the pen paddling with its
limbs; the sheep had been unremarkable at a neurological
examination a few days earlier. An adenoma of the pitui-
tary gland was diagnosed.
A Romney ewe (SM1453, ARQ/ARR, orally dosed with 5 g
of BSE brainstem at six months of age, culled at 91 mpi)
had difficulty standing for 15 minutes after a sudden fit
Table 4: Clinical findings in non-pruritic BSE cases of the oral BSE pathogenesis study
Animal SM1391 SM1430 SM1394 SP3652 SM1435 SM1404
Breed and genotype Romney ARQ/ARQ Romney ARQ/ARQ Romney ARQ/ARQ Suffolk ARQ/ARQ Romney ARQ/ARQ Romney ARQ/ARQ
MPI 16 16 22 16 22 22
Postmortem test result HP neg. IHC pos. HP neg. IHC pos. HP neg. IHC pos. HP neg. IHC pos. HP pos. IHC pos. HP pos. IHC pos.
Behaviour change No No No No N/A No
Pruritic behaviour1 No No Rubbing once No Rubbing once No
Fleece change No No No No No No
Skin Lesion No No No No No No
Bruxism when observed or 
examined
No No No No No No
Tremors No No No No N/A No
Ataxia No No No No No No
Weight loss No <5% No No <5% <5%
1 The display of a positive scratch test, a self-induced scratch response, self-nibbling, rubbing or scratching
HP = Histopathological examination of the brain
IHC = Immunohistochemical examination of the brain
neg./pos. = negative/positive
N/A = not assessed
Romney sheep were inoculated at approximately six months of age, Suffolk sheep at approximately four months of age.Page 5 of 15
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cephalopathy of undetermined but possible metabolic
origin and an abscess at the base of the tongue were
found.
A Romney ewe (SM1418, ARR/ARR, orally dosed with 5 g
of BSE brainstem at six months of age, culled at 97 mpi)
presented with weight loss, bruxism, head tremor and had
a history of fits. A diagnosis of leucoencephalopathy, pos-
sibly as a result of a metabolic disease, was made.
A Romney wether (SM1450, ARQ/ARR, orally dosed with
5 g of BSE brainstem at six months of age, culled at 104
mpi) had a history of occasional fits since 88 mpi; these
progressively became more frequent. In addition, the
sheep developed a left corneal oedema with ulceration
but no other clinical signs were seen. A leucoencephalop-
athy, similar to the previous two cases, was diagnosed.
Clinical progression
Table 5 displays the results of the survival analysis for 60
animals, including 23 BSE-positive sheep, which were
monitored clinically from approximately 13 mpi until
cull.
The analysis was compromised by the low number of
cases, in particular those that had no detectable PrPd in the
brain, which displayed some of the clinical signs used for
comparison, such as tremor or ataxia. BSE positive cases
displayed most signs significantly earlier than BSE-nega-
tive sheep, which included six undosed controls. Only the
first display of fleece changes and bruxism during the
examination when the animal was undisturbed (bruxism
when free) was not significantly different (see Additional
file 8: plots, which displays the plots of Kaplan-Meier esti-
mates for the first appearance of each clinical sign).
The clinical signs in 21 clinical suspects with confirmed
BSE that were monitored regularly from at least 20 weeks
prior to cull are displayed in Figures 1, 2, 3, 4. Signs usu-
ally progressed over a period of 20 weeks. Individual clin-
ical signs were usually displayed in single animals only or
expressed mildly (rubbing/scratching, nibbling and
weight loss) at 16 to 20 weeks prior to cull but became
more frequent or severe as the disease progressed.
Discussion
This study demonstrated that pruritus is a common fea-
ture in clinical cases of ovine BSE. Forty-one (87%) of the
47 BSE-positive sheep displayed signs of pruritus. A
repeatable stereotypical response (nibbling or head/body
movements) to the scratch test, which has been associated
with pruritus in sheep with scrapie [14], was elicited in
85% of 41 BSE-positive sheep.
The six non-pruritic BSE cases, which were culled at pre-
determined time points, displayed no specific signs of
neurological disease; three had minor loss of weight prior
to cull. Although the occurrence of even minor weight loss
was significantly greater in clinical BSE cases (see Table 3),
this sign is not specific for BSE and was also observed in
BSE-negative sheep at some stage during their life. Thus,
we concluded that these six sheep represented pre-clinical
BSE cases. All six sheep were culled between 16 and 22
Table 5: Survival analysis test to compare the times of the first appearance of a particular clinical sign in BSE positive and negative 
cases.
Presence during the monitoring period P-value *
Clinical sign Negative cases (n) Positive cases (n) Log-rank test Wilcoxon test
Behaviour change 17 16 ++
Rubbing/scratching 34 23 ns
Nibbling 25 21 +
Positive scratch test 4 18 +++
Fleece change 28 18 ns
Alopecia 4 14 +++
Skin lesions 5 10 +
Self-induced scratch response 7 18 +++
Bruxism when handled 9 9 +++
Bruxism when free during examination 7 5 ns
Bruxism at observation 17 17 +
Tremors 2 14 +++
Ataxia 2 13 +++
Weight loss 29 22 +
Loss of body condition 20 18 +++
* P-values: + ≤ 0.04;
++ ≤ 0.001;
+++ ≤ 0.0001;
ns statistically not significant (P > 0.05)Page 6 of 15
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tochemical examination of parts of the central nervous
system (CNS) [22]; three did not present with disease-spe-
cific vacuolation in the brain. As most previous studies of
experimental TSE in sheep do not include detailed clinical
assessments, it is difficult to know how frequently pre-
clinical cases may be detected by postmortem brain tests.
In one study, orally dosed sheep with scrapie displayed
early clinical signs around the same time as sparse PrPd
accumulation was detectable in the CNS whereas one nat-
urally infected sheep displayed no clinical signs and pre-
sented with vacuolation and PrPd accumulation in the
brain [23], similarly to our three non-pruritic BSE cases.
One sheep displayed a positive scratch test on two consec-
utive examinations prior to cull, which was highly sugges-
tive of BSE, even though PrPd was not detected in the brain
or lymphoreticular tissues of this sheep. Aside from TSEs,
a positive scratch response may be elicited in animals with
pruritic skin conditions, such as psoroptic mange [24,25].
This sheep showed no significant pruritic behaviour, alo-
pecia or skin lesions indicative of pruritus. Additionally,
searches for ectoparasites remained negative in several
"suspect" sheep tested at various time points throughout
the studies, suggesting that our sheep remained ectopara-
site free. Other pruritic behaviour (a self-induced nibble
reflex, occasional or frequent rubbing, scratching or nib-
bling) was also observed in 19 challenged sheep with at
least one ARR allele, which were not confirmed as BSE
cases by postmortem tests. Clinical and neurological signs
have been reported in experimentally challenged ARR/
ARR sheep with detectable PrPd in the brain [4]. If the pru-
ritic behaviour observed in our sheep was indeed caused
by BSE we would have expected that the disease was con-
firmed by postmortem tests. A clinical diagnosis of TSE is
more likely to be made if unequivocal neurological signs,
Behavioural signs displayed in 21 BSE cases observed over a period of 20 weeks prior to being culled because of disease pro-gressionFigure 1
Behavioural signs displayed in 21 BSE cases observed over a period of 20 weeks prior to being culled because 
of disease progression. The total number of animals per time period differed because not every sign was assessed during 
each period.Page 7 of 15
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Signs of pruritus displayed in 21 BSE cases observed over a period of 20 weeks prior to being culled because of disease pro-gres i nFigure 2
Signs of pruritus displayed in 21 BSE cases observed over a period of 20 weeks prior to being culled because of 
disease progression. The total number of animals per time period differed because not every sign was assessed during each 
period.
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several sheep developed skin lesions that led to culling for
welfare reasons at a time point preceding the onset of
ataxia in their cohort challenged group. The severity of the
skin lesions may not always reflect disease progression,
given the influence of other factors, such as the presence
of hard sharp surfaces in the pen and the sheep's individ-
ual propensity to rub or self mutilate. In addition, clinical
progression could not be monitored in the eleven BSE
cases that were culled at pre-determined time points to
study BSE pathogenesis and tissue distribution. However,
the clinical signs displayed by these sheep up to their cull
date were identical to those noted in their cohort chal-
lenge group, contributing to the establishment of the clin-
ical phenotype of BSE in each challenge group.
Six sheep inoculated with the BSE agent were culled due
to intercurrent diseases, five of which displayed neurolog-
ical signs without pruritus. All of these six sheep were
either homozygous or heterozygous R at codon 171, and
postmortem tests showed no evidence of BSE, as assessed
by the absence PrPd in the brain and lymphoreticular tis-
sue of these sheep, and none of the sheep in our studies
with this genotype have so far had BSE confirmed by post-
mortem tests. Three sheep with histopathological evi-
dence of leucoencephalopathy of undetermined origin
Signs of ataxia displayed in 21 BSE cases observed over a period of 20 weeks prior to being ull d because of disease rogressionFigu 3
Signs of ataxia displayed in 21 BSE cases observed 
over a period of 20 weeks prior to being culled 
because of disease progression. The total number of ani-
mals per time period differed because not every sign was 
assessed at each time.
Unspecific signs displayed in 21 BSE cases observed over a period of 20 week  prior to being culled because of disease rogress onFigu  4
Unspecific signs displayed in 21 BSE cases observed 
over a period of 20 weeks prior to being culled 
because of disease progression. The total number of ani-
mals per time period differed because not every sign was 
assessed at each time.Page 9 of 15
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loss of consciousness, salivation, urination or defecation,
which usually accompany seizures [26], were not
described. Seizures are most frequently associated with
focal or diffuse forebrain or thalamic lesions caused by
infections, toxins, tumours, nutritional deficiencies or
metabolic diseases [27]. A blood sample was not exam-
ined for the presence of metabolic disease (e.g. hypomag-
nesaemia, thiamine deficiency) but this as well as toxins
were considered unlikely because of the strict feeding and
housing regime used in our studies.
Our findings that sheep with BSE are generally pruritic
whereas ataxia is displayed later in the clinical course are
in contrast to the observations of others [17,21]. It is pos-
sible that the route of inoculation (oral dosing or natural
transmission in our experimental flocks) results in a dif-
ferent clinical presentation compared to parenteral inocu-
lation mostly used by others. Pruritus was not observed in
a limited number of BSE cases described in previous stud-
ies, but some of the sheep were kept at pasture and the
methods by which clinical signs were assessed or recorded
were not detailed [17,18]. The very detailed clinical mon-
itoring in our studies likely contributed to the detection of
signs of pruritus, which could have been overlooked in
another setting. During our prolonged passive observa-
tions, we noted that the sheep would initially "freeze" and
just stare at the observer, and that they would return to
their "normal" group activities only after the first 10–20
minutes of observation. This "freezing behaviour"
explains why pruritus was seldom witnessed during the
shorter daily or routine husbandry procedures, even in
cases that had displayed pruritus for some time during
passive observation sessions. Continuous video surveil-
lance may be a good alternative to prolonged observa-
tions, since it has been shown that initial signs of pruritus
were detected by video surveillance but were not apparent
to observers [28]. Another useful contribution to the
detection of signs of pruritus was the systematic assess-
ment of the scratch test, which was not used in previously
reported studies of BSE in sheep. One BSE-affected sheep,
which presented with a positive scratch test, tremor and
changed behaviour (initially nervousness and later dull-
ness), did not start pruritic activity until 20 minutes into
an observation session, indicating that episodes of pruritic
activity can be missed if sheep are observed for only a
short time. Pruritic activity may be increased in associa-
tion with resting behaviour in sheep. Disturbances caused
by noise or the presence of humans result in a decrease in
resting behaviour and an increase in movement and head
alert reactions in sheep [29], likely more so in nervous
sheep.
When the presence of each individual clinical sign was
compared between BSE-positive and negative cases over
the monitoring period from approximately 13 mpi until
cull, 13 of 15 signs appeared significantly earlier (P <
0.05) in BSE positive cases. For example, all positive cases
with observed bruxism during handling displayed this
sign before 122 weeks post inoculation (p.i.) whilst
approximately 89% of the BSE-negative cases presented
with this sign after 133 weeks. Only fleece changes and
bruxism during the examination when the sheep was
undisturbed (bruxism when free) were not displayed ear-
lier in positive or negative cases. Both are very unspecific
signs and may occur in "normal" animals. In addition,
every statistical analysis is dependent on the number of
observations. A low number of observations, as seen for
"bruxism when free", results in wide confidence intervals
or prevents meaningful statistical analysis, which is why
the degree of rubbing or nibbling was also not taken into
consideration for the survival analysis, although frequent
rubbing or nibbling was rarely or never observed in BSE-
negative cases (exposed sheep that were negative for PrPd
or unexposed controls) prior to cull.
Loss of weight was one of the first observed signs of BSE
and was seen significantly earlier in BSE-positive cases,
although it was also present in inoculated animals that
tested negative for BSE and in some control sheep (P <
0.05 by Wilcoxon test, see additional file 8: plots of the
Kaplan-Meier estimate for weight loss). It frequently coin-
cided with pruritic behaviour in BSE cases. Thus, limiting
the clinical assessment to weighing and a scratch test can
be done fairly quickly and may be an efficient way to
screen sheep for BSE.
It was not investigated whether age at dosing affected the
clinical presentation. Most of the sheep were challenged
between four and six months of age, and the number of
animals challenged at an older (nine months in AHQ/
AHQ sheep) or younger age (possibly in the perinatal
period in the two "naturally" infected animals) was too
small to allow any statistical analysis. A separate study
conducted in the UK where sheep were challenged with
BSE at various ages has not found any obvious link
between age of challenge, incubation period and type of
clinical sign [17].
The potential for discriminating TSE strains by the clinical
presentation was demonstrated in a mouse model where
different prion strains produced different behavioural
changes [30]. The authors hypothesised that this may also
apply to larger animals although the range of tests that can
be performed on sheep and cattle is obviously limited by
the size and cooperation of the animals. BSE in cattle (C-
type) is a neurological disease with a fairly uniform clini-
cal presentation characterised by changes in behaviour,
sensation and locomotion [31] and thought to be caused
by a uniform strain based on a similarly uniform distribu-Page 10 of 15
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mice [35,36]. If strains predominantly dictate the clinical
presentation, infection of sheep with the BSE agent
should equally result in a relatively uniform clinical dis-
ease, regardless of breed and genotype, since the patho-
logical phenotype, including the intracellular truncation
pattern, remains constant when BSE is transmitted to
sheep with different genotypes and by different routes
[37,38]. Our results show that BSE in sheep indeed
presents with a relatively uniform clinical disease with
pruritus as the predominant and initial sign, accompanied
by behavioural and later locomotor changes as the disease
progresses, and only rarely deficits of the menace
response. The two ARQ/ARQ Suffolk sheep inoculated
intracerebrally displayed pruritus in a similar fashion to
the BSE cases infected orally or naturally. A temporal dis-
tribution in the display of clinical signs has also been
shown in sheep scrapie, with an increased frequency of
altered mental status, pruritus with wool loss, teeth grind-
ing, head tremor, ataxia, loss of bodily condition and an
absent menace response as the disease progresses
[8,14,15,39]. Our findings suggest that the clinical presen-
tation of BSE in sheep of the susceptible or affected geno-
types is largely influenced by the strain rather than breed,
PrP genotype or route of inoculation although the vast
majority of BSE cases were orally challenged ARQ/ARQ
Romney or Suffolk sheep. More cases in other breeds or
genotypes including orally inoculated VRQ/VRQ sheep
need to be studied. Natural infection, although only
described in two cases in an experimental flock, did
present with similar clinical signs and incubation periods.
No other classical scrapie strain has yet been found in
sheep with similar uniform neuropathological, molecular
and biological characteristics as BSE. Clinical cases of
atypical scrapie, which may be caused by a single strain
based on the neuropathological and molecular character-
istics [40], display predominantly behavioural and loco-
motor abnormalities [10,11,41] but only very limited
cases have been studied so far. Well-characterised scrapie
isolates, such as SSPB/1 [42], produce a disease with vari-
able clinical presentation in which pruritus and ataxia are
displayed inconsistently in sheep of different breeds and
genotypes inoculated subcutaneously [21]. The variation
seen in the neuroanatomical distribution of vacuolar
changes and PrPd accumulation in the brain of sheep with
scrapie is believed to be affected not only by the scrapie
strain but also by sheep breed and host genotype
[16,43,44]. Differentiation of ovine BSE from scrapie may
not be possible based on clinical signs but our findings
suggest that a scrapie suspect without signs of pruritus,
such as the majority of atypical scrapie cases [10,11,41], is
unlikely to have BSE.
Conclusion
Oral BSE infection of Romney and Suffolk ARQ/ARQ
sheep causes a uniform disease with early pruritus fol-
lowed by behavioural changes and movement disorders
as the disease progresses. Identical findings in a limited
number of additional BSE cases described here suggest
that the clinical features are independent of breed, geno-
type or route of inoculation. It is hypothesised that the
clinical presentation in sheep is predominantly influ-
enced by the TSE strain. Screening susceptible sheep for
BSE may be done efficiently by regular monitoring of their
weights and testing them for a scratch response.
Methods
All procedures were approved under the Animal (Scien-
tific Procedures) Act 1986. Each dose group was housed
separately in medium security accommodations. The
sheep were fed hay and straw ad libitum and a ration of
feed concentrate free from animal protein/meat and bone
meal, mixed with minerals.
The 139 sheep studied were sourced from scrapie-free
flocks, which comprised clinically healthy castrated male
or female Romney (n = 71), Suffolk (n = 59), Poll Dorset
(n = 3) and Cheviot sheep (n = 6) of various genotypes
[ARQ/ARQ (n = 59), ARQ/ARR (n = 35), ARR/ARR (n =
39), AHQ/AHQ (n = 4) and VRQ/VRQ (n = 2)]. The sheep
were from four major BSE studies, an oral BSE pathogen-
esis study (n = 109) [22,45], a sheep to sheep BSE passage
study (n = 13), a BSE research flock study (n = 15) [46,47]
and a BSE tissue production study (n = 2).
Oral BSE pathogenesis study
The experimental design has been published in detail for
the Romney sheep study [22,45]. Briefly, 60 Romney and
56 Suffolk sheep of PrP genotypes ARQ/ARQ, ARQ/ARR
or ARR/ARR were orally inoculated with 5 g of brainstem
homogenate from histopathologically confirmed bovine
BSE cases at 4–6 months of age. Control groups com-
prised a total of 15 and ten undosed Romney and Suffolk
sheep, respectively, of the same genotypes. Sheep of the
ARQ/ARQ genotype were culled at 4–6 month intervals
from four to 22 mpi regardless of their clinical status; one
group of four animals was kept alive until the develop-
ment of clinical signs. Sheep of the ARQ/ARR (n = 18) and
ARR/ARR (n = 17) genotypes were culled at 12-month
intervals from 10 mpi to 46 mpi; the remaining animals
were kept alive until the development of clinical disease.
Another two ARR/ARR sheep were culled at 100–101 mpi
for a bioassay in transgenic mice. One control sheep was
culled at each timed cull of dosed animals.
Reported are the findings in 109 sheep, which included 61
Romney (19 ARQ/ARQ, 21 ARQ/ARR and ARR/ARR
respectively) and 48 Suffolk sheep (17 ARQ/ARQ, 13Page 11 of 15
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and 43 Suffolk sheep) was challenged with BSE.
Sheep to sheep passage study
Single oral doses of 0.0005 to 5 g (ten fold increase) brain
homogenate from BSE-affected sheep provided by the oral
BSE pathogenesis study were administered orally to sheep
of the same or different breed and genotype at approxi-
mately six months of age to assess if the strain characteris-
tics would change upon this second passage of BSE in
sheep. For the purpose of this paper, we analysed the clin-
ical findings in 13 sheep (four Romney, five Suffolk, three
Poll Dorset with ARQ/ARQ genotype and one Romney
with ARQ/ARR genotype), orally dosed with 5 g (n = 7),
0.5 g (n = 5) or 0.05 g (n = 1).
BSE research flock
Sheep dosed orally with 5 g of bovine BSE brain were bred
under strict biosecurity measures and mixed with
undosed sheep to assess whether BSE can be transmitted
naturally [46,47]. Animals were culled when they devel-
oped clinical disease.
Of the 12 sheep (four Suffolk and five Romney ARQ/ARQ
sheep and three Cheviots with genotype AHQ/AHQ [n =
1] and VRQ/VRQ [n = 2], respectively) used for the analy-
sis, ten were dosed ewes (age at dosing varied from four to
nine months of age), and two were the offspring of dosed
ewes, which included a Suffolk wether culled at 21
months of age [46] and a Romney ewe culled at 24
months of age.
BSE tissue production study
Four ARQ/ARQ Suffolk sheep were inoculated intracere-
brally with 1 ml of sterile bovine BSE brainstem (as a 10%
homogenate in physiological saline solution) at eight
months of age under general anaesthesia. Only two sheep
had developed disease at the time of writing (April 2008,
38 mpi).
Postmortem diagnosis
Diagnosis was made by immunohistochemical examina-
tion of the brain and – in case of a negative finding – lym-
phoreticular tissue, such as palatine tonsil, spleen, Peyer's
patches of the distal ileum and various lymph nodes [22].
Western immunoblot examination of the caudal medulla
("VLA hybrid technique" [48]) was performed in animals
negative by immunohistochemistry. The postmortem test
results were used as the "gold standard" for this study; i.e.
an animal that did not present with disease-associated
prion protein (PrPd) in any of the examined tissues was
considered as BSE negative, even if it was dosed.
Clinical methods
For the oral pathogenesis study, clinical monitoring con-
sisted of neurological examinations every three to four
months (from 13 mpi), weekly behavioural group obser-
vations for about 30 minutes (from 14 mpi), and quar-
terly six-hour group behavioural studies (from 12–62 mpi
in Romney sheep and 13–40 mpi in Suffolk sheep). Body
weights were recorded monthly. Any deviation from nor-
mal was also recorded during daily or periodical hus-
bandry procedures, such as feeding, cleaning of the pens,
and shearing. Any deviation from normal usually resulted
in more frequent neurological examinations and weigh-
ing sessions to determine clinical progression and the ani-
mals' fitness' to remain on the study (clinical end-point).
The clinical methods were similar for the sheep to sheep
passage study, apart from the exclusion of six-hour behav-
ioural studies. The sheep from the BSE research flock and
the BSE tissue production study were only examined once
prior to cull.
The neurological examination [49] included gait assess-
ment, testing of cranial nerve reflexes, and an evaluation
of the scratch test response. For the scratch test, the ani-
mals were lightly restrained and scratched systematically
along the dorsum. The scratch test was positive (positive
scratch response) if the animal repeatedly displayed obvi-
ous stereotypical behaviour, such as nibbling movements
of the lips or lip licking ("nibble reflex") or rhythmical
head or body movements. An inconclusive scratch test
result, such as occasional chewing movements or incon-
sistent stereotypical responses was considered "negative"
for the purpose of this paper.
The clinical signs assessed at weekly behavioural observa-
tions included pruritic behaviour, such as scratching, rub-
bing on objects or nibbling at body parts. If animals
displayed a distinct and repeatable stereotypical behav-
iour such as lip licking or smacking while rubbing parts of
their body, this was recorded as a "self-induced scratch
response". Other clinical signs noted included bruxism,
snorting (voluntary expulsion of air through the nostrils),
sneezing, yawning or flehmen, all of which have been
observed in cattle with BSE [50]. Comments were also
made on any deviation from normal sheep behaviour
within the group (e.g. standing separate from the others)
and when the observer entered the pen at the end of the
observation period. The signs assessed during six-hour
behavioural studies were similar although the pen was not
entered at the end of these observations.
All examinations and observations were carried out
according to a standard protocol originally set up by a cer-
tified veterinary neurologist (CBB). Each sign was defined,
and the examiners/observers were trained to make the
assessments as uniform as possible.Page 12 of 15
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gression the incubation times were divided into four-week
intervals and all signs displayed within each interval start-
ing from the cull date were taken into consideration. Rub-
bing/scratching, nibbling and bruxism were graded from
0–4 (0 = never observed in a four-week interval, 1 =
observed once, 2 = observed for up to 50% of the behav-
ioural observations, 3 = observed for more than 50% of
the behavioural observations). Weight loss was graded
from 0–4 (0 = weight gain, 1 = weight remained the same
compared to last weighing, 2 = weight loss of 5% or less
of the previous body weight, 3 = weight loss between 5
and 10%, 4 = weight loss of more than 10%). The pres-
ence of other clinical signs was recorded as either "no" (=
0) or "yes" (= 1).
Behavioural changes included dull or nervous behaviour
(not seen previously) and separation from the group. Skin
lesions included excoriation, papules, lichenification or
oedema, which have been observed in cases of scrapie
[14,51]. Fleece changes included strips of wool hanging
from the fleece or wool discolouration on the dorsum,
shoulder or flank, which may have been the result of pru-
ritus. Bruxism observed during the examination was dis-
tinguished from bruxism during passive behavioural
observations because stress and handling may provoke
teeth grinding even in healthy sheep (T Konold, unpub-
lished observation).
Whether a given clinical sign was present in a sheep in a
specific four-week interval could not always be assessed.
For example weight loss could not be assessed if the ani-
mal had recently been shorn, nervous behaviour during
handling could not be classified as "changed behaviour"
if the sheep had not been handled previously. In addition,
some clinical assessments were not possible during a foot
and mouth disease epidemic in 2001 when access to the
sheep accommodation was restricted to animal hus-
bandry staff only.
As tremor in scrapie-affected sheep may only be evident
when the animal is managed or driven [14,15] the assess-
ment of tremor was only considered to be reliable when
assessed at neurological examinations; the absence of this
sign on passive observations was regarded as "not
assessed" because it might have been displayed if the ani-
mal was stressed.
Clinical disease was suspected if sheep displayed a posi-
tive scratch test.
Statistical analysis
The software packages SAS/STAT for Windows, version 9.1
(SAS International, Heidelberg, Germany), and Statistica,
version 8 (StatSoft Inc., Tulsa, USA), were used. Individual
clinical signs between positive and negative cases were
compared by Fisher's exact test. Survival analysis (log-rank
test and Wilcoxon test if the assumption of proportional
hazards was not fulfilled) was used for clinical signs
observed during the period of clinical monitoring by com-
paring the times of the first appearance of a particular clin-
ical sign in positive and negative cases. For this analysis,
only the presence or absence of a clinical sign was used,
and the grading system for the signs rubbing/scratching,
nibbling, bruxism at observation and weight loss was
ignored.
A P-value of less than 0.05 was considered to be statisti-
cally significant.
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"Scratch response in orally challenged VRQ/VRQ sheep". Cheviot ewe 
(VRQ/VRQ, animal T1714) at 51 months after oral challenge with 5 g 
of BSE brainstem homogenate. This ewe responds to scratching of the dor-
sum initially with raising of the head and lowering of the hind quarters 
but eventually displays a scratch response (nibbling).




"Scratch response in an intracerebrally inoculated ARQ/ARQ sheep". Suf-
folk wether (ARQ/ARQ, animal 05–1015) at 18 months after intracere-
bral inoculation with BSE brainstem homogenate. Scratching of the 
dorsum elicits a scratch response with excessive bending of the neck to the 
right/upwards.




"Self-induced scratch response". Romney ewe (ARQ/ARQ, animal 
SM1406) at 37 month after oral challenge with 5 g of BSE brainstem 
homogenate. Rubbing of the dorsum on the water trough induces a scratch 
response (nibbling).
Click here for file
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Additional file 4
"Self-nibbling". Group of four Suffolk sheep (ARQ/ARQ) at 17 months 
after intracerebral inoculation with BSE brainstem homogenate. Two 
sheep (wether 05–1015, lying next to black plastic drum, and ewe 05–
1022, lying down in front of the camera) display pruritic behaviour, such 
as nibbling of the left flank and/or hind limb. Around the same time, both 
sheep also displayed a scratch response when the dorsum was scratched 
(see animal 05–1015 in additional file 2). The other two sheep were still 
clinically healthy 20 months later.




"Scratch response in orally challenged ARQ/ARQ sheep". Romney ewe 
(ARQ/ARQ, animal SR5169) at 25 months after oral challenge with 0.5 
g of BSE brainstem homogenate. This sheep displays a scratch response 
(nibbling) when the dorsum at the level of the thoracic spinal column is 
scratched. Even mere touching of the sheep's dorsum further caudal elicits 
a brief 'nibble' as can be seen at the end of the clip.




"Scratch response in an orally challenged AHQ/AHQ sheep". Cheviot ewe 
(AHQ/AHQ, animal 06–1069) at 18 months after oral challenge with 
5 g of BSE brainstem homogenate. This ewe responds to scratching with 
raising of the head only when restrained during the scratch test, but dis-
plays rhythmical lip and body movements when scratched whilst standing 
freely in the pen.




"Ataxia with mild proprioceptive deficits in orally challenged ARQ/ARQ 
sheep". Romney ewe (ARQ/ARQ, animal SR5169) at 25 months after 
oral challenge with 0.5 g of BSE brainstem homogenate (see additional 
file 5). Whilst testing the proprioceptive positioning response of the right 
hind limb the ewe is briefly knuckling over its left hind fetlock when it tries 
to correct the position of the right hind limb. It displays a 'swaying gait' 
with occasional abnormal placement of the hind limbs. (Note the very 
slight loss of balance with leaning to the left when the ewe approaches the 
end of the corridor a second time.)




Plots of Kaplan-Meier estimates for the first appearance of each clinical 
sign in negative and positive BSE cases.
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